The Synthesis of Cinchonine Tiglat Ester Compound and Cytotoxic Test Against MCF-7 Breast Cancer Cell
Abstract
Cinchonine is a type of cinchona alkaloid compound commonly found and/or isolated from Cinchona sp. plant. It is commonly used to treat malaria, and can potentially be used against cancer cells. In this particular study, cinchonine ester derivatives were extracted through esterification processs. Synthesized esther is aimed to gain higher lipophilicity of cinchonine so that makes it easier to pass through cell membrane. Esterification was done using DCC activator as well as DMAP catalyst with tiglic acid used to create cinchonine tiglat. Subsequent cinchonine tiglat was obtained in the form of oil with 25,28% yield. The compound obtained from the synthesis was the analyzed using LC-ESI-MS and 1H-NMR spectroscopy instrumentation. Results show that the target compound has been successfully synthesized. Its cytotoxic ability against MCF-7 breast cancer cells was tested using the Alamar Blue method. Results concluded that cinchonine tiglat ester compound has a viable cytotoxic activity with IC50 value of 1.22 ppm.
Full Text:
PDFReferences
Ferlay J, Soerjomataram I, Ervik M, et al; International Agency for Research on Cancer. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. globocan.iarc.fr. Accessed December 12, 2013
Lindsey A. Torre, MSPH1 ; Freddie Bray, PhD2 ; Rebecca L. Siegel, MPH3 ; Jacques Ferlay, ME4 ; Joannie Lortet-Tieulent, MSc5 ; Ahmedin Jemal, DVM, Ph D2015 Global Cancer Statistics, 2012 CA: A Cancer Journal for Clinicians 2015;65:87–108DOI: 10.3322/caac.21262
Kundu, C.N., Satria D., Anmada N., Shakti, R.S., Dipon D., & Sumit S. (2015). Review: Anti-malarials are anti-cancers and vice versa - One arrow two sparrows. Acta Tropica, 149, 113–127. http://doi.org/10.1016/j.actatropica.2015.03.028
Krishnaveni, M., and Kathiresan S., 2015, A Study on Protective Effect of Quinine against Lipid Peroxidation and Antioxidants Status in Human Oral Cancer Cell Line, Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 6 (5), hlm 295-231, ISSN: 0975-8585
Károlyi, B.I., B?sze, S., Orbán, E., Sohár, P., Drahos, L., Gál, E., and Csámpai, A., 2012, Acylated mono-, bis- and tris- Cinchona-Based Amines Containing Ferrocene or Organic Residues: Synthesis, Structure and in Vitro Antitumor Activity on Selected Human Cancer Cell Lines, journal molecules, vol. 17, hal. 2316-2329, ISSN 1420-3049, doi:10.3390/molecules17032316
Preet, R., Mohapatra, M., Mohanty, S., Sahu, S.K., Choundhuri, T., Wyatt, M.D., and kundu, C.N., 2012, Qunacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity, Int. J. cancer, vol. 130, 1660-1670.
Wu, D. 2003. Studies on novel heterocyclic compounds and their microbicidal efficacy. Tetrahedron. 59, 8649-8687
Mfan, S., Anand, K., Anandakumar, S., Singh, S., Chuturgoon, A. A., & Gengan, R. M. (2016). Discipline of Medical Biochemistry , School of Laboratory Medicine and Medical Sciences ,. JPB. http://doi.org/10.1016/j.jphotobiol.2016.10.009
Achan, J., Talisuna, A.O., Erhart, A., Yeka, A., Tibenderana, J.K., Baliraine, F.N., Rosen-thal, P.J., D’Alessandro, U., 2011. Quinine, an old anti-malarial drug in a modernworld: role in the treatment of malaria. Malar. J. 10, 144.
Schlesinger, P.H., Krogstad, D.J., Herwaldt, B.I., 1988. Antimalarial agents: mecha-nisms of action. Antimicrob. Agents Chemother. 32, 793–798.
Mohapatra, P., Preet, R., Das, D., Satapathy, S.R., Choudhuri, T., Wyatt, M.D., Kundu,C.N., 2012. Quinacrine-mediated autophagy and apoptosis in colon cancer cellsis through a p53- and p21-dependent mechanism. Oncol. Res. 20, 81–91.
Genne, P., Duchamp P., Solary E., Pinard D., Belon J.P., Dimanche Boitrel M.T., Chauffert B., 1994, Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM, Leukemia, 8: 160–164.
Furusawa, S., Nakano, S., Wu, J., Sakaguchi, S., Takayanagi, M., Sasaki, K., and Satoh, S., 2001, Apoptosis induced by doxorubicin and cinchonine in P388 multidrug-resistant cells, Journal of Pharmacy and Pharmacology, 53: 1029–1039.
Lee, S., Rhee, Y., Jeong, S., Lee, H., Jung, M., Kim, S., Lee, E., Ahn, K.S., Kim, S.H., 2009, Hydrocinchonine, Cinchonine, and Quinidine Potentiate Paclitaxel-Induced Cytotoxicity and Apoptosis via Multidrug Resistance Reversal in MES-SA/DX5 Uterine Sarcoma Cells, Environmental Toxicology, 26: 424–431
Genne, P., Dimanche-Boitrel M.T., Mauvernay R.Y., Gutierrez G., Duchamp O., Petit J.M., Martin F., Chauffert B., 1992, Cinchonine, a potent ef?ux inhibitor to circumvent anthracycline resistance in vitro and in vivo, Cancer Res, 52: 2797–2801.
Genne, P., Duchamp P., Solary E., Magnette J., Belon J.P., Chauffert B., 1995, Cinchonine per os: ef?cient circumvention of P-glycoproteinmediated multidrug resistance, Anti-Cancer Drug Design, 10: 103–118.
Lehnert, M., 1998, Chemotherapy resistance in breast cancer, Anticancer Res, 18: 2225–2226
Beaumont, K., Webster, R., Gardner, I. & Dack, K. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Curr. Drug Metab. 4, 461–485 (2003).
Sanda, & Radu, R. (2012). Contribution to cinchona alkaloids chemistry, 1–46.
Kumura, N., Izumi, M., Jima, S. N., Shimizu, S., Kim, S., Wataya, Y., Baba, N. B. (2005). Synthesis and Biological Activity of Fatty Acid Derivatives of Quinine, Biosci, Biotechnol, Biochem, 69 (11), 2250-2253. http://doi.org/10.1271/bbb.69.2250
Mario, Puspa D.N.L., Gian P., Sylvia R.P., and Muhammad H. 2017. Synthesis and cytotoxicity assay using Brine Shrimp Lethality Test of Cinchonidine Isobutyrate Ester. Indonesian Journal of Applied Chemistry. 19(1), 29-35, e-ISSN:2527-7669.
M V Lancaster, R D Fields. 1996, Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents, U.S Patent, 5501959 A
Fessenden, R.J., & Fessenden, J.S. 1991. Kimia Organik Edisi III jilid I (III). Massachuset: Penerbit Erlangga.
Page, A.B., Page, A.M., and Noel, C., 1993, A new fluorimetric assay for cytotoxicity measurements in vitro, Int. J. Oncol, 3, 473–476
Lipinski, C.A., Lombardo, F., Dominy, B.W., & Feeney, P.J., 1997, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Advanced Drug Delivery Reviews, 23 (1± 3), 3 ±25
Zampieri, L., Bianchi, P., Ruff, P., and Arbuthnot, P., 2002, Differential Modulation by Estradiol of P-glycoprotein Drug Resistance Protein Expression in Cultured MCF7 and T47D Breast Cancer Cells, Anticancer Res., 22, 2253-2259.
Refbacks
- There are currently no refbacks.